. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Angiogenesis Inhibitors/therapeutic useClinical Trials, Phase III as TopicColorectal Neoplasms/drug therapyColorectal Neoplasms/pathologyHumansIndoles/therapeutic useProtein-Tyrosine Kinases/antagonists & inhibitorsPyrroles/therapeutic useReceptor Protein-Tyrosine Kinases/antagonists & inhibitorsReceptors, Growth Factor/antagonists & inhibitorsReceptors, Vascular Endothelial Growth Factor
Substances: See more » Angiogenesis InhibitorsIndolesPyrrolesReceptors, Growth FactorSemaxinibProtein-Tyrosine KinasesReceptor Protein-Tyrosine KinasesReceptors, Vascular Endothelial Growth Factor
Year: 2002 PMID: 12113066 DOI: 10.1586/14737140.2.1.5
Source DB: PubMed Journal: Expert Rev Anticancer Ther ISSN: 1473-7140 Impact factor: 4.512